You are here: Industry Insights > CSIR-IICT

News List

CSIR-IICT, Anthem Biosciences partner to produce anti-COVID drug 2-DG expresspharma
June 17, 2021
The CSIR-Indian Institute of Chemical Technology (IICT) and Bengaluru-based Anthem Biosciences have entered into an agreement for technology transfer and manufacture of anti-COVID drug 2-DG.
CSIR-IICT, NIIST, Suven Pharma sign MoU for Molnupiravir expresspharma
June 11, 2021
The anti-viral drug was initially developed for the treatment of influenza and has been repurposed to treat COVID-19.
Bharat Biotech, Biovet, Sapigen Biologix enter into research pact with CSIR-IICT expresspharma
March 30, 2021
To collaborate on the development of novel platform technologies for biotherapeutics and vaccines to support indigenous, affordable health care solutions for humans and animals.
APIIC signs MoU with CSIR-IICT to establish a bulk drug park expresspharma
September 04, 2020
CSIR-IICT will be the knowledge partner and offer technical support for the proposal to be submitted to the DoP.
CSIR-IICT develops cost effective process technology for Favipiravir expresspharma
July 27, 2020
The research lab announced that its had transferred the technology to Cipla, which has recently DCGI for permission to launch the COVID-19 treatment in India.
CSIR-IICT ties up with Cipla to develop anti-COVID-19 drug expresspharma
March 20, 2020
Hyderabad-based CSIR – Indian Institute of Chemical Technology (IICT) has tied up with pharmaceutical giant Cipla to work on development of anti-viral drugs to contain COVID-19.
Sun Pharma Announces Licensing Agreement With CSIR-IICT expresspharma
August 15, 2019
Sun Pharmaceuticals has announced that it has entered into a global licensing agreement with the CSIR Indian Institute of Chemical Technology, Hyderabad (CSIR-IICT), for patents related to certain compounds with ...